Market Overview

Earnings Calendar Scheduled for July 9th, 2013

Share:
Related HITK
Hi-Tech Pharmacal Receives FDA Final Approval for Bromfenac Ophthalmic Solution, 0.09%
US Stock Futures Up; Jobless Claims Data In Focus
Related WWW
Wolverine World Wide Upgraded By This Firm, But Bulls Be Warned
Benzinga's Top Upgrades
Strong read from NPD on athletic footwear amid social fitness trend (Seeking Alpha)

Pre-Market:

Hi-Tech Pharmacal (NASDAQ: HITK) - Q4 2013 EPS estimate of $0.68 and revenue estimate of $66.70 million

Wolverine World Wide (NYSE: WWW) - Q2 2013 EPS estimate of $0.34 and revenue estimate of $591.03 million

SemiLEDS (NASDAQ: LEDS) - Q3 2013 EPS estimate of $(0.24) and revenue estimate of $5.17 million

Penford (NASDAQ: PENX) - Q3 2013 EPS estimate of $0.15

After-Hours:

ADTRAN (NASDAQ: ADTN) - Q2 2013 EPS estimate of $0.16 and revenue estimate of $154.16 million

Healthcare Services Group (NASDAQ: HCSG) - Q2 2013 EPS estimate of $0.20 and revenue estimate of $281.77 million

Franklin Covey (NYSE: FC) - Q3 2013 EPS estimate of $0.11 and revenue estimate of $43.28 million

Helen of Troy Limited (NASDAQ: HELE) - Q1 2014 EPS estimate of $0.69 and revenue estimate of $301.50 million

Posted-In: Earnings News Guidance Markets

 

Related Articles (ADTN + FC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters